Focus Contact

LeafBio, Inc. is the commercialization arm of Mapp Biopharmaceutical.


September 17, 2015 - ZMapp™ is Granted Fast Track Status by the FDA

June 10, 2015 - Mapp signs contract with Public Health Agency of Canada.

February 27, 2015 - Mapp Bio Clinical Trials Press Release

February 6, 2015 - LeafBio, Inc. submitted an Investigational New Drug (IND) application for clinical evaluation of ZMapp™ to the Food and Drug Administration (FDA) on February 3, 2015.

July 15, 2014 - Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical

August 21, 2013 - Experimental Ebola Treatment Protects Some Primates Even After Disease Symptoms Appear

ZMapp™ Information Sheet

ZMapp™ Frequently Asked Questions